tiprankstipranks

Helen Torley Insider Profile

4 Followers
Helen Torley, President & CEO, Director at Halozyme, holds 676.74K shares in Halozyme (Ticker: HALO), holds 6.26K shares in Quest Diagnostics (Ticker: DGX), holds 2.25K shares in Relypsa Inc (Ticker: RLYP).
tipranks
Helen Torley

Helen Torley
Halozyme (HALO)
President & CEO, Director

Ranked #28,347 out of 98,564 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+58.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$27M
96.99%
3.01%
A breakdown of Helen Torley's holdings

Insider Roles

Halozyme
(HALO)
President & CEO, Director
Quest Diagnostics
(DGX)
Director
Roles that Helen Torley holds in companies

Most Profitable Insider Trade

Stock:
Halozyme
(HALO)
Rating:Informative Buy
Date:Sep 16, 2014 - Sep 16, 2015
Return:+103.60%
The most profitable trade made by Helen Torley

Helen Torley's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Halozyme
Feb 20, 2024
President & CEO, Director
Uninformative Buy
735.07K
$26.20M
Quest Diagnostics
May 25, 2021
Director
Uninformative Buy
$814.36K
RLYP
Relypsa Inc
Jun 23, 2016
Uninformative Buy
$71.98K
ONXX
Onyx Pharma
List of latest transactions for each holding click on a transaction to see Helen Torley's performance on stock

Helen Torley insider profile FAQ

What is the percentage of profitable transactions made by Helen Torley?
The percentage of profitable transactions made by Helen Torley is 100%.
    What is the average return per transaction made by Helen Torley?
    The average return per transaction made by Helen Torley is 58.90%.
      What stocks does Helen Torley hold?
      Helen Torley holds: HALO, DGX, RLYP, ONXX stocks.
        What was Helen Torley’s latest transaction?
        Helen Torley latest transaction was an Uninformative Buy of $735.07K.
          What was Helen Torley's most profitable transaction?
          Helen Torley’s most profitable transaction was an Informative Buy of HALO stock on September 16, 2014. The return on the trade was 103.60%.
            What is Helen Torley's role in Halozyme?
            Helen Torley's role in Halozyme is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.